| Sharlynn Y Flores, LCSW | |
|
629 Cranbury Rd Fl 2, East Brunswick, NJ 08816-4096 | |
| (732) 390-7750 | |
| (732) 390-7725 |
| Full Name | Sharlynn Y Flores |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 8 Years |
| Location | 629 Cranbury Rd Fl 2, East Brunswick, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922614577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 44SC05941100 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Titan Health Partners Llc | 3971915349 | 58 |
News Archive
Babies born to pregnant women taking the epilepsy drug lamotrigine may not be at an increased risk of birth defects, such as cleft lip, cleft palate or clubfoot, according to a study published in the April 6, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
Women with higher risk scores that consisted of having certain genetic variants most strongly linked to breast cancer had an associated higher risk of breast cancer, with these scores also highly predictive of estrogen receptor-positive disease, according to a study in the July 28 issue of JAMA.
Affymetrix, Inc. today announced the launch of QuantiGene® ViewRNA Assay formats, which enable a new era of "in situ multiplex gene expression analysis" by allowing drug screening of native cells and advancing the pace of biomarker disease research and stem cell studies. These in situ assays enable researchers to visualize gene expression in individual cells at an unprecedented level of sensitivity and speed.
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
› Verified 9 days ago
| Entity Name | Vimax Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922440627 PECOS PAC ID: 7416273644 Enrollment ID: O20150306001011 |
News Archive
Babies born to pregnant women taking the epilepsy drug lamotrigine may not be at an increased risk of birth defects, such as cleft lip, cleft palate or clubfoot, according to a study published in the April 6, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
Women with higher risk scores that consisted of having certain genetic variants most strongly linked to breast cancer had an associated higher risk of breast cancer, with these scores also highly predictive of estrogen receptor-positive disease, according to a study in the July 28 issue of JAMA.
Affymetrix, Inc. today announced the launch of QuantiGene® ViewRNA Assay formats, which enable a new era of "in situ multiplex gene expression analysis" by allowing drug screening of native cells and advancing the pace of biomarker disease research and stem cell studies. These in situ assays enable researchers to visualize gene expression in individual cells at an unprecedented level of sensitivity and speed.
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
› Verified 9 days ago
| Entity Name | Titan Health Partners Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790396281 PECOS PAC ID: 3971915349 Enrollment ID: O20201209002560 |
News Archive
Babies born to pregnant women taking the epilepsy drug lamotrigine may not be at an increased risk of birth defects, such as cleft lip, cleft palate or clubfoot, according to a study published in the April 6, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
Women with higher risk scores that consisted of having certain genetic variants most strongly linked to breast cancer had an associated higher risk of breast cancer, with these scores also highly predictive of estrogen receptor-positive disease, according to a study in the July 28 issue of JAMA.
Affymetrix, Inc. today announced the launch of QuantiGene® ViewRNA Assay formats, which enable a new era of "in situ multiplex gene expression analysis" by allowing drug screening of native cells and advancing the pace of biomarker disease research and stem cell studies. These in situ assays enable researchers to visualize gene expression in individual cells at an unprecedented level of sensitivity and speed.
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sharlynn Y Flores, LCSW 629 Cranbury Rd Fl 2, East Brunswick, NJ 08816-4096 Ph: (732) 390-7750 | Sharlynn Y Flores, LCSW 629 Cranbury Rd Fl 2, East Brunswick, NJ 08816-4096 Ph: (732) 390-7750 |
News Archive
Babies born to pregnant women taking the epilepsy drug lamotrigine may not be at an increased risk of birth defects, such as cleft lip, cleft palate or clubfoot, according to a study published in the April 6, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.
Women with higher risk scores that consisted of having certain genetic variants most strongly linked to breast cancer had an associated higher risk of breast cancer, with these scores also highly predictive of estrogen receptor-positive disease, according to a study in the July 28 issue of JAMA.
Affymetrix, Inc. today announced the launch of QuantiGene® ViewRNA Assay formats, which enable a new era of "in situ multiplex gene expression analysis" by allowing drug screening of native cells and advancing the pace of biomarker disease research and stem cell studies. These in situ assays enable researchers to visualize gene expression in individual cells at an unprecedented level of sensitivity and speed.
The anti-diabetic drug phenformin may prompt stronger cancer-fighting activities than its sister compound metformin, a finding that could have major implications for current and future clinical trials investigating both agents for their anti-cancer potential, according to researchers at Massachusetts General Hospital (MGH).
› Verified 9 days ago
Erica Rodriguez, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15 W Prospect St, East Brunswick, NJ 08816 Phone: 732-254-0600 | |
Ms. Stephanie Loretta Willoughby, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6 Cornwall Ct Ste B, East Brunswick, NJ 08816 Phone: 732-955-4141 | |
Debra Gail Kaufman, L.C.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1 Ruth St, East Brunswick, NJ 08816 Phone: 732-887-7901 | |
Tatiana Larina, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 31 Ellwood Rd, East Brunswick, NJ 08816 Phone: 732-390-3371 | |
Felene Weinstein Weinstein Schwartz, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6 Thrush Dr, East Brunswick, NJ 08816 Phone: 732-710-2109 | |
William Launay Faughnan, LSW, MSW, BA Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 15 W Prospect St, East Brunswick, NJ 08816 Phone: 732-254-0600 Fax: 732-254-8606 | |
Simone Waters, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 16 Emerson St, East Brunswick, NJ 08816 Phone: 848-229-4412 |